Empowered Patient Podcast

Maria Picone, co-founder TREND.Community and Antonio Maltese, student with Huntington's Disease talk about the challenges of finding valid information about rare diseases, the value of community support in discovering novel approaches to treatments, providing evidence to pharmaceutical companies about little understood symptoms, and advocating for awareness about rare diseases particularly during Rare Disease week and Rare Disease Day February 29.

#rarediseases #huntingtonsdisease

HopeForHuntingtons.com

TREND.Community

Listen to the podcast here

Maria Picone, co-founder TREND.Community and Antonio Maltese, student with Huntington's Disease talk about the challenges of finding valid information about rare diseases, the value of community support in discovering novel approaches to treatments, providing evidence to pharmaceutical companies about little understood symptoms, and advocating for awareness about rare diseases particularly during Rare Disease week and Rare Disease Day February 29.

#rarediseases #huntingtonsdisease

HopeForHuntingtons.com

TREND.Community

Download the transcript here

Brad Margus, CEO, Cerevance talks about discovering and developing novel therapies for central nervous system diseases using the Cerevance powerful NETSseq target discovery platform and their large collection of human brain tissue samples. Brad explains why the brain is such a challenging organ to study and their efforts to understand brain cell loss in such diseases as Parkinson's and Alzheimer's.

#brain #CNSdisorders #Parkinsons #Alzheimers #NETSseq

Cevevance.com

Listen to the podcast here

Sponsored by

Brad Margus, CEO, Cerevance talks about discovering and developing novel therapies for central nervous system diseases using the Cerevance powerful NETSseq target discovery platform and their large collection of human brain tissue samples. Brad explains why the brain is such a challenging organ to study and their efforts to understand brain cell loss in such diseases as Parkinson's and Alzheimer's.

#brain #CNSdisorders #Parkinsons #Alzheimers #NETSseq

Cevevance.com

Download the transcript here

Brad Robinson, CEO, Predictive Technology Group talks about the company's work focusing on women's health and why they decided to focus on this neglected field that has significant unmet medical needs. Brad discusses the importance of genetics in informing a woman's course of care. Brad also talks about the company's subsidiaries Predictive Analytics, Predictive Laboratories, and Predictive Biotech and how the synergy between these entities is instrumental in helping women and their clinicians address endometriosis and other reproductive health concerns.

#womenshealth #endometriosis #infertility #fertility #genetics #pregnancy #preeclampsia

PredTechGroup.com

Listen to the podcast here.

Sponsored by:

TREND.Community

Brad Robinson, CEO, Predictive Technology Group talks about the company's work focusing on women's health and why they decided to focus on this neglected field that has significant unmet medical needs. Brad discusses the importance of genetics in informing a woman's course of care. Brad also talks about the company's subsidiaries Predictive Analytics, Predictive Laboratories, and Predictive Biotech and how the synergy between these entities is instrumental in helping women and their clinicians address endometriosis and other reproductive health concerns.

#womenshealth #endometriosis #infertility #fertility #genetics #pregnancy #preeclampsia

PredTechGroup.com

Download the transcript here

Ulf Jungnelius MD, CEO, Isofol Medical discusses the increasing incidence of colorectal cancer as a global issue and the current challenges in treating this devastating disease. Dr. Jungnelius also talks about the company's drug candidate, arfolitixorin, currently being studied in a global Phase 3 clinical trial with the aim to improve the efficacy of standard of care chemotherapy for advanced colorectal cancer.

#colorectalcancer #CRC #ColonCancer #MetastaticColorectalCancer #chemotherapy #FirstLineTreatment

Isofolmedical.com

Listen to the podcast here

Sponsored by:

TREND.Community

Ulf Jungnelius MD, CEO, Isofol Medical discusses the increasing incidence of colorectal cancer as a global issue and the current challenges in treating this devastating disease. Dr. Jungnelius also talks about the company's drug candidate, arfolitixorin, currently being studied in a global Phase 3 clinical trial with the aim to improve the efficacy of standard of care chemotherapy for advanced colorectal cancer.

#colorectalcancer #CRC #ColonCancer #MetastaticColorectalCancer #chemotherapy #FirstLineTreatment

Isofolmedical.com

Download the transcript here

Purnanand Sarma, CEO, Immunome discusses why a lot of cancers still remain untreatable today and the company's new approach to fight cancer by tapping into the body's natural immune response against disease. Sarma further talks about why Immunome chose to look at cancer through the lens of the B-cell in order to identify novel antibody-target pairs.

#BCell #Antibody #ImmuneResponse #cancer

Immunome.com

Listen to the podcast here

Sponsored by

Purnanand Sarma, CEO, Immunome discusses why a lot of cancers still remain untreatable today and the company's new approach to fight cancer by tapping into the body's natural immune response against disease. Sarma further talks about why Immunome chose to look at cancer through the lens of the B-cell in order to identify novel antibody-target pairs.

#BCell #Antibody #ImmuneResponse #cancer

Immunome.com

Download the transcript here